GUJRATHI SHEILA

CIK 00015752028 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001575202

Recent Transactions

50 trades

Award
Processa Pharmaceuticals, Inc.$PCSA
Series A Preferred Stock
2026-07-28+70,811.877→ 70,811.877 total
Award
Processa Pharmaceuticals, Inc.$PCSA
Series A Preferred Stock
2026-07-28+12,311.279→ 12,311.279 total
Disposition to Issuer
Ventyx Biosciences, Inc.$VTYX
Stock Option (Right to Buy)
2026-03-04−33,000→ 0 total
Disposition to Issuer
Ventyx Biosciences, Inc.$VTYX
Stock Option (Right to Buy)
2026-03-04−40,000→ 0 total
Disposition to Issuer
Ventyx Biosciences, Inc.$VTYX
Stock Option (Right to Buy)
2026-03-04−15,937→ 0 total
Disposition to Issuer
Ventyx Biosciences, Inc.$VTYX
Stock Option (Right to Buy)
2026-03-04−21,825→ 0 total
Disposition to Issuer
Ventyx Biosciences, Inc.$VTYX
Stock Option (Right to Buy)
2026-03-04−277,941→ 0 total
Disposition to Issuer
Ventyx Biosciences, Inc.$VTYX
Stock Option (Right to Buy)
2026-03-04−80,000→ 0 total
Disposition to Issuer
Ventyx Biosciences, Inc.$VTYX
Stock Option (Right to Buy)
2026-03-04−662,369→ 0 total
Disposition to Issuer
Ventyx Biosciences, Inc.$VTYX
Common Stock
2026-03-04−130,000→ 0 total
Award
Janux Therapeutics, Inc.$JANX
Common Stock
2025-06-11+3,750→ 118,889 total
Award
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2025-06-11+11,667→ 11,667 total
Award
Ventyx Biosciences, Inc.$VTYX
Stock Option (Right to Buy)
2025-06-05+40,000→ 40,000 total
Purchase
Ventyx Biosciences, Inc.$VTYX
Common Stock
2024-12-23$2.31/sh+130,000→ 130,000 total
Other
Janux Therapeutics, Inc.$JANX
Common Stock
2024-11-05+4,611→ 115,139 total
Award
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2024-06-26+8,350→ 8,350 total
Award
Janux Therapeutics, Inc.$JANX
Common Stock
2024-06-26+2,500→ 110,528 total
Award
Ventyx Biosciences, Inc.$VTYX
Stock Option (Right to Buy)
2024-06-06+33,000→ 33,000 total
Other
Janux Therapeutics, Inc.$JANX
Common Stock
2024-02-29+2,986→ 108,028 total
Award
Ventyx Biosciences, Inc.$VTYX
Stock Option (Right to Buy)
2024-01-21+80,000→ 80,000 total
Award
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2023-06-14+12,500→ 12,500 total
Award
Ventyx Biosciences, Inc.$VTYX
Stock Option (right to buy)
2023-06-08+15,937→ 15,937 total
Sale
Ventyx Biosciences, Inc.$VTYX
Common Stock
2023-03-30$33.73/sh−100,000→ 0 total
Exercise/Conversion
Ventyx Biosciences, Inc.$VTYX
Stock Option (Right to Buy)
2023-03-30−100,000→ 662,369 total
Exercise/Conversion
Ventyx Biosciences, Inc.$VTYX
Common Stock
2023-03-30$6.03/sh+100,000→ 100,000 total
Gift
Ventyx Biosciences, Inc.$VTYX
Common Stock
2022-12-21−32,987→ 0 total
Award
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2022-06-14+12,500→ 12,500 total
Award
Ventyx Biosciences, Inc.$VTYX
Stock Option (right to buy)
2022-06-09+21,825→ 21,825 total
Award
Ventyx Biosciences, Inc.$VTYX
Stock Option (right to buy)
2022-06-09+13,301→ 13,301 total
Award
Ventyx Biosciences, Inc.$VTYX
Stock Option (right to buy)
2021-12-02+277,941→ 277,941 total
Conversion
Ventyx Biosciences, Inc.$VTYX
Common Stock
2021-10-25+32,897→ 32,897 total
Conversion
Ventyx Biosciences, Inc.$VTYX
Series A Preferred Stock
2021-10-25−32,897→ 0 total
Award
Turning Point Therapeutics, Inc.
Stock Option (right to buy)
2020-06-15+8,500→ 8,500 total
Award
Gossamer Bio, Inc.$GOSS
Common Stock
2020-02-14+189,500→ 189,500 total
Award
Gossamer Bio, Inc.$GOSS
Stock Option (right to buy)
2020-02-14+292,000→ 292,000 total
Purchase
Gossamer Bio, Inc.$GOSS
Common Stock
2019-09-27$16.80/sh+10,000→ 4,048,242 total
Award
Turning Point Therapeutics, Inc.
Stock Option (right to buy)
2019-04-22+15,000→ 15,000 total
Award
Gossamer Bio, Inc.$GOSS
Stock Option (right to buy)
2019-03-25+380,000→ 380,000 total
Conversion
Gossamer Bio, Inc.$GOSS
Series A Preferred Stock
2019-02-12−223,182→ 0 total
Conversion
Gossamer Bio, Inc.$GOSS
Series B Preferred Stock
2019-02-12−55,957→ 0 total
Conversion
Gossamer Bio, Inc.$GOSS
Common Stock
2019-02-12+62,030→ 4,038,242 total
Award
FIVE PRIME THERAPEUTICS, INC.
Stock Option (right to buy)
2018-05-10+10,000→ 10,000 total
Award
FIVE PRIME THERAPEUTICS, INC.
Stock Option (right to buy)
2017-05-10+10,000→ 10,000 total
Award
FIVE PRIME THERAPEUTICS, INC.
Stock Option (right to buy)
2016-05-19+10,000→ 0 total
Award
FIVE PRIME THERAPEUTICS, INC.
Stock Option (right to buy)
2015-12-02+25,000→ 25,000 total
Disposition to Issuer
Receptos, Inc.
Employee Stock Option (right to buy)
2015-08-27$223.90/sh−26,666→ 0 total
Disposition to Issuer
Receptos, Inc.
Common Stock
2015-08-27−12,500→ 0 total
Disposition to Issuer
Receptos, Inc.
Employee Stock Option (right to buy)
2015-08-27$190.49/sh−55,418→ 0 total
Disposition to Issuer
Receptos, Inc.
Employee Stock Option (right to buy)
2015-08-27$213.23/sh−129,400→ 0 total
Disposition from Tender
Receptos, Inc.
Common Stock
2015-08-25−120,661→ 12,500 total

Companies

Recent Filings

Address

C/O BLOSSOMHILL THERAPEUTICS, INC. 10255 SCIENCE CENTER DRIVE, SUITE 200

SAN DIEGO, CA, 92121

View on SEC.gov